The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Synopsis
Opioids are a class of drugs that include the illegal drug heroin, synthetic opioids such as fentanyl, and pain relievers available legally by prescription, such as oxycodone (OxyContin®), hydrocodone (Vicodin®), codeine, morphine, and many others. These drugs are chemically related and interact with opioid receptors on nerve cells in the body and brain.
The global Opioids market was valued at US$ 10050 million in 2023 and is anticipated to reach US$ 14730 million by 2030, witnessing a CAGR of 5.5% during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Opioids, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Opioids.
Report Scope
The Opioids market size, estimations, and forecasts are provided in terms of sales volume (MT) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Opioids market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Opioids manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company (Partial List):
- Teva
- Purdue Pharma
- Mallinckrodt
- Amneal Pharma
- Collegium
- J&J
- Endo
- Pfizer
- INSYS
- Mylan
- Hikma
- Egalet
Segment by Type
- Oxycodone
- Hydromorphone
- Codeine
- Fentanyl
- Other
Segment by Application
- Pain Relief
- Anesthesia
- Cough Suppression
- Diarrhea Suppression
- Deaddiction
- Others
Consumption by Region
- North America (United States, Canada)
- Europe (Germany, France, U.K., Italy, Russia)
- Asia-Pacific (China, Japan, South Korea, India, Australia, China Taiwan, Indonesia, Thailand, Malaysia)
- Latin America (Mexico, Brazil, Argentina)
- Middle East & Africa (Turkey, Saudi Arabia, UAE)
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Opioids manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Opioids in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index
1 Opioids Market Overview
1.1 Product Overview and Scope of Opioids
1.2 Opioids Segment by Type
1.2.1 Global Opioids Market Value Comparison by Type (2024-2030)
1.2.2 Oxycodone
1.2.3 Hydromorphone
1.2.4 Codeine
1.2.5 Fentanyl
1.2.6 Other
1.3 Opioids Segment by Application
1.3.1 Global Opioids Market Value by Application: (2024-2030)
1.3.2 Pain Relief
1.3.3 Anesthesia
1.3.4 Cough Suppression
1.3.5 Diarrhea Suppression
1.3.6 Deaddiction
1.3.7 Others
1.4 Global Opioids Market Size Estimates and Forecasts
1.4.1 Global Opioids Revenue 2019-2030
1.4.2 Global Opioids Sales 2019-2030
1.4.3 Global Opioids Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Opioids Market Competition by Manufacturers
2.1 Global Opioids Sales Market Share by Manufacturers (2019-2024)
2.2 Global Opioids Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Opioids Average Price by Manufacturers (2019-2024)
2.4 Global Opioids Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Opioids, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Opioids, Product Type & Application
2.7 Opioids Market Competitive Situation and Trends
2.7.1 Opioids Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Opioids Players Market Share by Revenue
2.7.3 Global Opioids Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Opioids Retrospective Market Scenario by Region
3.1 Global Opioids Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Opioids Global Opioids Sales by Region: 2019-2030
3.2.1 Global Opioids Sales by Region: 2019-2024
3.2.2 Global Opioids Sales by Region: 2025-2030
3.3 Global Opioids Global Opioids Revenue by Region: 2019-2030
3.3.1 Global Opioids Revenue by Region: 2019-2024
3.3.2 Global Opioids Revenue by Region: 2025-2030
3.4 North America Opioids Market Facts & Figures by Country
3.4.1 North America Opioids Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Opioids Sales by Country (2019-2030)
3.4.3 North America Opioids Revenue by Country (2019-2030)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Opioids Market Facts & Figures by Country
3.5.1 Europe Opioids Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Opioids Sales by Country (2019-2030)
3.5.3 Europe Opioids Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Opioids Market Facts & Figures by Country
3.6.1 Asia Pacific Opioids Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Opioids Sales by Country (2019-2030)
3.6.3 Asia Pacific Opioids Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Opioids Market Facts & Figures by Country
3.7.1 Latin America Opioids Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Opioids Sales by Country (2019-2030)
3.7.3 Latin America Opioids Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Opioids Market Facts & Figures by Country
3.8.1 Middle East and Africa Opioids Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Opioids Sales by Country (2019-2030)
3.8.3 Middle East and Africa Opioids Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global Opioids Sales by Type (2019-2030)
4.1.1 Global Opioids Sales by Type (2019-2024)
4.1.2 Global Opioids Sales by Type (2025-2030)
4.1.3 Global Opioids Sales Market Share by Type (2019-2030)
4.2 Global Opioids Revenue by Type (2019-2030)
4.2.1 Global Opioids Revenue by Type (2019-2024)
4.2.2 Global Opioids Revenue by Type (2025-2030)
4.2.3 Global Opioids Revenue Market Share by Type (2019-2030)
4.3 Global Opioids Price by Type (2019-2030)
5 Segment by Application
5.1 Global Opioids Sales by Application (2019-2030)
5.1.1 Global Opioids Sales by Application (2019-2024)
5.1.2 Global Opioids Sales by Application (2025-2030)
5.1.3 Global Opioids Sales Market Share by Application (2019-2030)
5.2 Global Opioids Revenue by Application (2019-2030)
5.2.1 Global Opioids Revenue by Application (2019-2024)
5.2.2 Global Opioids Revenue by Application (2025-2030)
5.2.3 Global Opioids Revenue Market Share by Application (2019-2030)
5.3 Global Opioids Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Teva
6.1.1 Teva Corporation Information
6.1.2 Teva Description and Business Overview
6.1.3 Teva Opioids Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Teva Opioids Product Portfolio
6.1.5 Teva Recent Developments/Updates
6.2 Purdue Pharma
6.2.1 Purdue Pharma Corporation Information
6.2.2 Purdue Pharma Description and Business Overview
6.2.3 Purdue Pharma Opioids Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Purdue Pharma Opioids Product Portfolio
6.2.5 Purdue Pharma Recent Developments/Updates
6.3 Mallinckrodt
6.3.1 Mallinckrodt Corporation Information
6.3.2 Mallinckrodt Description and Business Overview
6.3.3 Mallinckrodt Opioids Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Mallinckrodt Opioids Product Portfolio
6.3.5 Mallinckrodt Recent Developments/Updates
6.4 Amneal Pharma
6.4.1 Amneal Pharma Corporation Information
6.4.2 Amneal Pharma Description and Business Overview
6.4.3 Amneal Pharma Opioids Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Amneal Pharma Opioids Product Portfolio
6.4.5 Amneal Pharma Recent Developments/Updates
6.5 Collegium
6.5.1 Collegium Corporation Information
6.5.2 Collegium Description and Business Overview
6.5.3 Collegium Opioids Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Collegium Opioids Product Portfolio
6.5.5 Collegium Recent Developments/Updates
6.6 J&J
6.6.1 J&J Corporation Information
6.6.2 J&J Description and Business Overview
6.6.3 J&J Opioids Sales, Revenue and Gross Margin (2019-2024)
6.6.4 J&J Opioids Product Portfolio
6.6.5 J&J Recent Developments/Updates
6.7 Endo
6.6.1 Endo Corporation Information
6.6.2 Endo Description and Business Overview
6.6.3 Endo Opioids Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Endo Opioids Product Portfolio
6.7.5 Endo Recent Developments/Updates
6.8 Pfizer
6.8.1 Pfizer Corporation Information
6.8.2 Pfizer Description and Business Overview
6.8.3 Pfizer Opioids Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Pfizer Opioids Product Portfolio
6.8.5 Pfizer Recent Developments/Updates
6.9 INSYS
6.9.1 INSYS Corporation Information
6.9.2 INSYS Description and Business Overview
6.9.3 INSYS Opioids Sales, Revenue and Gross Margin (2019-2024)
6.9.4 INSYS Opioids Product Portfolio
6.9.5 INSYS Recent Developments/Updates
6.10 Mylan
6.10.1 Mylan Corporation Information
6.10.2 Mylan Description and Business Overview
6.10.3 Mylan Opioids Sales, Revenue and Gross Margin (2019-2024)
6.10.4 Mylan Opioids Product Portfolio
6.10.5 Mylan Recent Developments/Updates
6.11 Hikma
6.11.1 Hikma Corporation Information
6.11.2 Hikma Opioids Description and Business Overview
6.11.3 Hikma Opioids Sales, Revenue and Gross Margin (2019-2024)
6.11.4 Hikma Opioids Product Portfolio
6.11.5 Hikma Recent Developments/Updates
6.12 Egalet
6.12.1 Egalet Corporation Information
6.12.2 Egalet Opioids Description and Business Overview
6.12.3 Egalet Opioids Sales, Revenue and Gross Margin (2019-2024)
6.12.4 Egalet Opioids Product Portfolio
6.12.5 Egalet Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Opioids Industry Chain Analysis
7.2 Opioids Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Opioids Production Mode & Process
7.4 Opioids Sales and Marketing
7.4.1 Opioids Sales Channels
7.4.2 Opioids Distributors
7.5 Opioids Customers
8 Opioids Market Dynamics
8.1 Opioids Industry Trends
8.2 Opioids Market Drivers
8.3 Opioids Market Challenges
8.4 Opioids Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
